Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Seema A. Khan, MD
Robert H. Lurie Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
377 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute at University of Alberta
Edmonton, Alberta, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Saint John Regional Hospital
Saint John, New Brunswick, Canada
- London Regional Cancer Program at London Health Sciences Centre
London, Ontario, Canada
- Mcgill Cancer Centre at Mcgill University
Montreal, Quebec, Canada
- Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel
- King Faisal Specialist Hospital and Research Center
Riyadh, Saudi Arabia
- Pretoria Academic Hospital
Pretoria, South Africa
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Providence Cancer Center
Anchorage, Alaska, United States
- Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Enloe Cancer Center at Enloe Medical Center
Chico, California, United States
- North Bay Cancer Center
Fairfield, California, United States
- California Cancer Care, Incorporated - Greenbrae
Greenbrae, California, United States
- Todd Cancer Institute at Long Beach Memorial Medical Center
Long Beach, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Community Hospital of the Monterey Peninsula Comprehensive Cancer Center
Monterey, California, United States
- El Camino Hospital Cancer Center
Mountain View, California, United States
- Ccop - Bay Area Tumor Institute
Oakland, California, United States
- St. Joseph Hospital Regional Cancer Center - Orange
Orange, California, United States
- Doctors Medical Center - San Pablo Campus
San Pablo, California, United States
- Stanford Cancer Center
Stanford, California, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
- Presbyterian - St. Luke'S Medical Center
Denver, Colorado, United States
- Exempla Lutheran Medical Center
Wheat Ridge, Colorado, United States
- Saint Francis/mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
- Norwalk Hospital
Norwalk, Connecticut, United States
- Eastern Connecticut Hematology and Oncology Associates
Norwich, Connecticut, United States
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Herbert D. Kerman Regional Oncology Center - Daytona Beach
Daytona Beach, Florida, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- Florida Hospital Cancer Institute at Florida Hospital Orlando
Orlando, Florida, United States
- M.D. Anderson Cancer Center at Orlando
Orlando, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Tampa, Florida, United States
- Emory Crawford Long Hospital
Atlanta, Georgia, United States
- Georgia Cancer Center for Excellence at Grady Memorial Hospital
Atlanta, Georgia, United States
- Northside Hospital Cancer Center
Atlanta, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 May 2011
- Primary completion
- 10 Dec 2019
- Completion
- 21 Dec 2022
- Last update posted
- 29 Jun 2023
- Registered enrollment
- 390
- Registry id
- NCT01242800
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.